Tenderwize
Back to tender search

Diltiazem drug discount agreements

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Sep 30, 2027 · 314 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Diltiazem, ATC C08DB01

48/100

Opportunity Score

Needs reviewHigh complexity
SuppliesOpen
Why this score?

Opportunity

48 / 100

Complexity

67 / 100

Risk factors

The notice provides no contract value, quantities, expected utilization, or detailed commercial conditions.

Open-house agreements may end automatically if exclusive rebate agreements become effective during the term.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Sep 30, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Nov 2027
  • Conclusion of non-exclusive pharmaceutical rebate agreements under Sections 130a(8) and 130c(1) SGB V for medicines containing Diltiazem, ATC C08DB01.
  • Participation is available to interested pharmaceutical companies without a competitive selection decision.
Show full summary

Open-house, non-exclusive pharmaceutical rebate agreements for Diltiazem (ATC C08DB01) offered by AOK Rheinland-Pfalz/Saarland to all interested pharmaceutical companies without a selection decision. Contracts may be concluded monthly during the maximum 24-month period, subject to uniform non-negotiable conditions. The initial contract-start submission deadline was 31 October 2025; later access is possible until 30 September 2027, subject to the contract documents. Procurement documents were not analyzed, and no contract value is provided.

Risks

The notice provides no contract value, quantities, expected utilization, or detailed commercial conditions.

Open-house agreements may end automatically if exclusive rebate agreements become effective during the term.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The participant must be a pharmaceutical company.
  • Only approved medicines that are marketable in Germany may be supplied under the contract.
  • Listing in the Lauer-Taxe may serve as evidence of marketability.

Requirements may be incomplete.

Buyer

Lots (1)

LOT-0001

Open-house Diltiazem pharmaceutical rebate agreements

Non-exclusive rebate agreements for medicines containing Diltiazem, ATC C08DB01. All interested pharmaceutical companies may join under identical conditions; individual negotiations are not conducted. Pediatric medicines listed under the relevant BfArM list are excluded. Contracts may start on the first day of a month, end no later than 30 November 2027, and may terminate automatically if exclusive agreements replace the open-house contracts.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Nov 2025 - Nov 2027

Category

Pharmaceutical products

Deadline

Deadline Sep 30, 2027

Procurement Details

Publication date
15 Oct 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
682674-2025

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy